Skip to main content
. Author manuscript; available in PMC: 2016 Mar 15.
Published in final edited form as: J Community Support Oncol. 2015 Mar;13(3):113–116. doi: 10.12788/jcso.0117

TABLE 1.

Risk factors for intermediate risk of febrile neutropenia

1. Older than 65 years
2. Previous chemotherapy or radiation therapy
3. Preexisting neutropenia or documented bone marrow involvement with tumor
4. Preexisting conditions, such as infection/open wounds at chemotherapy initiation
5. Recent surgery (within 6 weeks of chemotherapy)
6. Poor performance status (Eastern Cooperative Oncology Group PS, 2-4)
7. Poor nutrition status
8. Poor renal function (creatinine clearance, <30 ml/min)
9. Liver dysfunction (bilirubin, >2 mg/dL)